Evidence map›Paper›PMID 21116829›Full record

ArticleJournal of gastroenterology2011

A polymorphism in the integrin αV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients.

Tatsuo Inamine, Minoru Nakamura, Ayumi Kawauchi, Yayoi Shirakawa, Hisae Hashiguchi, Yoshihiro Aiba, Akinobu Taketomi, Ken Shirabe, Makoto Nakamuta, Shigeki Hayashi and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Proposed therapies in primary biliary cholangitis.Expert review of gastroenterology & hepatology · 2016
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Tatsuo InamineDepartment of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Minoru Nakamura
Ayumi Kawauchi
Yayoi Shirakawa
Hisae Hashiguchi
Yoshihiro Aiba
Akinobu Taketomi
Ken Shirabe
Makoto Nakamuta
Shigeki Hayashi
Takeo Saoshiro
Atsumasa Komori
Hiroshi Yatsuhashi
Shinji Kondo
Katsuhisa Omagari
Yoshihiko Maehara
Hiromi Ishibashi
Kazuhiro Tsukamoto
PBC Study Group in NHOSLJ
Nagasaki Medical Center · JPKyushu University · JPNagasaki University · JPNational Hospital Organization · JPUniversity of Nagasaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccumulating evidence indicates that multiple genetic factors are involved in the pathogenesis of primary biliary cirrhosis (PBC). The aim of this study was to investigate whether polymorphisms of the integrin αV subunit gene (ITGAV), a component of integrin αVβ6, which plays an important role in the process of fibrosis, are associated with susceptibility to the onset and/or progression of PBC.

methodsIn the primary study, eight tag single nucleotide polymorphisms (SNPs) in ITGAV were analyzed by polymerase chain reaction (PCR)-restriction fragment length polymorphism, direct DNA sequencing, or high-resolution melting curve analysis in 309 Japanese patients with PBC who were registered in the National Hospital Organization Study Group for Liver Disease in Japan (PBC cohort I) and 293 gender-matched healthy Japanese volunteers (control subjects). For the replication study, 35 PBC patients who progressed to end-stage hepatic failure and underwent liver transplantation (PBC cohort II) were also analyzed.

resultsThree tag SNPs (rs3911238, rs10174098, and rs1448427) in ITGAV were significantly associated with the severe progression of PBC, but not with susceptibility to the onset of PBC, in the primary study (PBC cohort I). Among these SNPs, rs1448427 was also significantly associated with the severe progression to end-stage hepatic failure in the replication study of PBC patients who underwent liver transplantation (PBC cohort II).

conclusionsITGAV is a genetic determinant for the severe progression of PBC in Japanese patients. Genetic polymorphisms of ITGAV may be useful for identifying high-risk Japanese PBC patients, including those who will require liver transplantation, at the time of initial diagnosis.

Indexed as

AdultAgedAsian PeopleCase-Control StudiesDisease ProgressionEnd Stage Liver DiseaseFemaleGenetic Predisposition to DiseaseHumansIntegrin alphaVJapanLiver Cirrhosis, BiliaryLiver TransplantationMaleMiddle AgedPolymorphism, Restriction Fragment LengthIntegrin alphaV

Identifiers

PMID21116829
OpenAlexW1966690620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.